Guenther v. Novartis Pharmaceutical Corp.

Order

GREGORY A. PRESNELL, District Judge.

This matter comes before the Court without a hearing on the Motion for Judgment Notwithstanding the Verdict (Doc. 307) filed by the Defendant, Novartis Pharmaceutical Corporation (“Novartis”), the response in opposition (Doc. 308) filed by the Plaintiffs, and the reply (Doc. 311) filed by Novartis.

I. Background

Novartis produces and markets Zometa, a prescription drug. Nancy Guenther1 took Zometa and developed osteonecrosis of the jaw (henceforth, “ONJ”). In March 2008, she sued Novartis, alleging that Zometa had caused the ONJ and that Novartis had…